Profil bibliographique

Jessica Rubens

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

30Publications signalées

330Citations signalées

2Affiliations récentes

Institutions déclarées

Johnson & Johnson (United States)Johnson & Johnson (Israel)

Domaines associés

Psoriasis: Treatment and PathogenesisDermatology and Skin DiseasesSpondyloarthritis Studies and TreatmentsVirology and Viral DiseasesImmune responses and vaccinations

Publications récentes

Accès ouvert 2026 article

Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, -TOTAL, and -ADVANCE 1 and 2 Phase 3 Trials

Adis journals on behalf of:, Mark Lebwohl, Melinda Gooderham, Richard B Warren et autres

0 citationsFigshare

Accès ouvert 2026 article

Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, -TOTAL, and -ADVANCE 1 and 2 Phase 3 Trials

Adis journals on behalf of:, Mark Lebwohl, Melinda Gooderham, Richard B Warren et autres

0 citationsFigshare

Accès ouvert 2026 article

Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials

Mark Lebwohl, Melinda Gooderham, Richard B. Warren, Lawrence F. Eichenfield et autres

0 citationsDermatology and Therapy

Accès ouvert 2026 article

Durability of response to icotrokinra for high‐impact site psoriasis: 1‐year ICONIC ‐ TOTAL findings

Richard B. Warren, Melinda Gooderham, Edward Lain, Robert Bissonnette et autres

1 citationJournal of the European Academy of Dermatology and Venereology

2025 article

097 Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that selectively inhibits the IL-23–receptor

Melinda Gooderham, Edward Lain, R. Bissonette, Yonghong Huang et autres

0 citationsJournal of Investigative Dermatology

2025 article

ICONIC-TOTAL : résultats d’un essai de phase 3 avec icotrokinra, peptide oral ciblé bloquant sélectivement le récepteur de l’interleukine-23 dans le traitement des localisations difficiles à traiter et à fort impact du psoriasis en plaque

M. Gooderham, Z. Reguiaï, T. Lain, Robert Bissonnette et autres

0 citationsAnnales de Dermatologie et de Vénéréologie - FMC

2025 article

Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites

Melinda Gooderham, Edward Lain, Robert Bissonnette, Yu‐Huei Huang et autres

16 citationsNEJM Evidence

2025 conference-abstract

LB1142 Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that selectively inhibits the IL-23–receptor

Melinda Gooderham, Edward Lain, R. Bissonnette, Yonghong Huang et autres

3 citationsJournal of Investigative Dermatology

Accès ouvert 2025 conference-abstract

POS1071 Treatment of Plaque Psoriasis Involving High-Impact Areas with Icotrokinra, a Targeted Oral Peptide That Selectively Binds the Interleukin-23–Receptor: Results Through Week 16 of the Phase 3, Randomized, Double-blind, Placebo-Controlled ICONIC-TOTAL Trial

M. Gooderham, Edward Lain, R. Bissonnette, Yonghong Huang et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2025 article

Safety, Immunogenicity, and Protective Efficacy in Rhesus Macaques of a Novel Recombinant Hemagglutinin Protein Measles Virus Vaccine

Jessica Rubens, Jacqueline Brockhurst, Shristi Ghimire, Jinjin Wu et autres

4 citationsThe Journal of Infectious Diseases

2024 conference-abstract

B and T cell repertoire and gene expression differences in measles infection and vaccination revealed by longitudinal single-cell RNA/VDJ sequencing

Kwan Pui Chan, Jessica Rubens, Maggie L. Bartlett, Jacqueline Brockhurst et autres

0 citationsThe Journal of Immunology

Accès ouvert 2023 conference-abstract

Mechanism(s) of long-term humoral immunity and immune suppression induced by wildtype Measles virus in rhesus macaques

Li‐Ting Liu, Maggie L. Bartlett, Jessica Rubens, Shristi Ghimire et autres

0 citationsThe Journal of Immunology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.